Biomea Fusion, Inc. (BMEA)

1.335 -0.16 (-10.40%) USD  |  NASDAQ  |  Sep 25, 15:02
More

Biomea Fusion Cash and Short Term Investments (Quarterly) : 35.19M for June 30, 2026

Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for BMEA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 35.19M
March 31, 2026 45.06M
December 31, 2025 55.81M
September 30, 2025 46.64M
June 30, 2025 56.22M
March 31, 2025 35.86M
December 31, 2024 58.28M
September 30, 2024 87.95M
June 30, 2024 113.29M
March 31, 2024 144.92M
December 31, 2023 176.87M
September 30, 2023 199.09M
Date Value
June 30, 2023 222.91M
March 31, 2023 86.30M
December 31, 2022 113.05M
September 30, 2022 133.46M
June 30, 2022 149.63M
March 31, 2022 164.81M
December 31, 2021 173.52M
September 30, 2021 189.40M
June 30, 2021 198.57M
March 31, 2021 45.48M
December 31, 2020 61.70M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
REGENXBIO, Inc. 105.74M
ACADIA Pharmaceuticals, Inc. 956.47M
Alnylam Pharmaceuticals, Inc. 3.308B
Anika Therapeutics, Inc. 38.41M
Savara, Inc. 173.03M